Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Redegeld

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Allergy|June 28, 2020
Immune modulation via T regulatory cell enhancement: Disease-modifying therapies for autoimmunity and their potential for chronic allergic and inflammatory diseases-An EAACI position paper of the Task Force on Immunopharmacology (TIPCO)Franziska Roth-Walter, Ian M Adcock, Cristina Benito-Villalvilla, et al.
Allergy|July 22, 2024
Granulocytes and mast cells in AllergoOncology-Bridging allergy to cancer: An EAACI position paperMariona Pascal, Heather J Bax, Christoph Bergmann, et al.
The Journal of Allergy and Clinical Immunology|June 4, 2013
Antigen-specific, antibody-coated, exosome-like nanovesicles deliver suppressor T-cell microRNA-150 to effector T cells to inhibit contact sensitivityKrzysztof Bryniarski, Wlodzimierz Ptak, Asha Jayakumar, et al.
Allergy|February 13, 2022
AllergoOncology: Danger signals in allergology and oncology: A European Academy of Allergy and Clinical Immunology (EAACI) Position PaperChristoph Bergmann, Aurélie Poli, Ioana Agache, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Allergy|June 28, 2020
Immune modulation via T regulatory cell enhancement: Disease-modifying therapies for autoimmunity and their potential for chronic allergic and inflammatory diseases-An EAACI position paper of the Task Force on Immunopharmacology (TIPCO)Franziska Roth-Walter, Ian M Adcock, Cristina Benito-Villalvilla, et al.
Allergy|July 22, 2024
Granulocytes and mast cells in AllergoOncology-Bridging allergy to cancer: An EAACI position paperMariona Pascal, Heather J Bax, Christoph Bergmann, et al.
The Journal of Allergy and Clinical Immunology|June 4, 2013
Antigen-specific, antibody-coated, exosome-like nanovesicles deliver suppressor T-cell microRNA-150 to effector T cells to inhibit contact sensitivityKrzysztof Bryniarski, Wlodzimierz Ptak, Asha Jayakumar, et al.
Allergy|February 13, 2022
AllergoOncology: Danger signals in allergology and oncology: A European Academy of Allergy and Clinical Immunology (EAACI) Position PaperChristoph Bergmann, Aurélie Poli, Ioana Agache, et al.
Pageof 4